PREPARATION AND USE OF ANDROGENIC COMPOUNDS Read more about PREPARATION AND USE OF ANDROGENIC COMPOUNDS Australia2001249661Filed on 2001-03-30
Utergolobin In The Treatment Of IgA Mediated Autoimmune Disorders Read more about Utergolobin In The Treatment Of IgA Mediated Autoimmune Disorders New Zealand515588Filed on 2000-04-13
Uteroglobin in The Treatment of IgA Meditated Automimmune Disorders Read more about Uteroglobin in The Treatment of IgA Meditated Automimmune Disorders European Patent00923335.4Filed on 2000-04-13
Utergolobin in The Treatment of IgA Meditated Automimmune Disorders Read more about Utergolobin in The Treatment of IgA Meditated Automimmune Disorders Canada2370738Filed on 2000-04-13
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE Read more about ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE Japan7-509336Filed on 1994-09-15
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE Read more about ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE European Patent94928126.5Filed on 1994-09-15
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE Read more about ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE Canada2171740Filed on 1994-09-15
ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE Read more about ORALLY ACTIVE DERIVATIVES OF 1, 3, 5(10) - ESTRATRIENE Australia77284/94Filed on 1994-09-15
NOVEL RESTRICTION ENDONUCLEASE Read more about NOVEL RESTRICTION ENDONUCLEASE Canada593938Filed on 1989-03-17
NOVEL RESTRICTION ENDONUCLEASE Read more about NOVEL RESTRICTION ENDONUCLEASE Australia33559/89Filed on 1989-03-17